Keywords: Abbott Labs, Financial results, Second-quarter 2012

Abbott continues to see earnings growth, beating 2nd-qtr expectations

Article | 19 July 2012

Print This

US health care group Abbott Laboratories (NYSE: ABT), which is scheduled to split into two separate companies, posted a healthy ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in